Search Results - "Nancey, Stephane"

Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID by Chapuis-Biron, Constance, Kirchgesner, Julien, Pariente, Benjamin, Bouhnik, Yoram, Amiot, Aurélien, Viennot, Stéphanie, Serrero, Mélanie, Fumery, Mathurin, Allez, Matthieu, Siproudhis, Laurent, Buisson, Anthony, Pineton de Chambrun, Guillaume, Abitbol, Vered, Nancey, Stéphane, Caillo, Ludovic, Plastaras, Laurianne, Savoye, Guillaume, Chanteloup, Elise, Simon, Marion, Dib, Nina, Rajca, Sylvie, Amil, Morgane, Parmentier, Anne-Laure, Peyrin-Biroulet, Laurent, Vuitton, Lucine

“…New therapeutic options for patients with Crohn's disease (CD) with perianal lesions failing anti-tumor necrosis factor (TNF) agents are needed. We aimed to…”
Get full text

Vedolizumab for perianal Crohn’s disease: a multicentre cohort study in 151 patients by Chapuis‐Biron, Constance, Bourrier, Anne, Nachury, Maria, Nancey, Stéphane, Bouhnik, Yoram, Serrero, Mélanie, Armengol‐Debeir, Laura, Buisson, Anthony, Tran‐Minh, My‐Linh, Zallot, Camille, Fumery, Mathurin, Bouguen, Guillaume, Abitbol, Vered, Viennot, Stéphanie, Chanteloup, Elise, Rajca, Sylvie, Dib, Nina, Parmentier, Anne‐Laure, Peyrin‐Biroulet, Laurent, Vuitton, Lucine, Pariente, Benjamin, Boschetti, Gilles, Gay, Claire, Briot, Charline, Seksik, Philippe, Stefanescu, Carmen, Allimant, Christophe, Siproudhis, Laurent

“…Summary Background The management of Crohn's disease patients with perianal lesions and anti‐TNF failure is challenging. Aims To assess the effectiveness of…”
Get full text

Prominence of ileal mucosa-associated microbiota to predict postoperative endoscopic recurrence in Crohn's disease by Sokol, Harry, Brot, Loic, Stefanescu, Carmen, Auzolle, Claire, Barnich, Nicolas, Buisson, Anthony, Fumery, Mathurin, Pariente, Benjamin, Le Bourhis, Lionel, Treton, Xavier, Nancey, Stéphane, Allez, Matthieu, Seksik, Philippe

“…Following ileal resection for Crohn's disease (CD), recurrence is very frequent. Although several clinical risk factors of recurrence have been identified,…”
Get more information

Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study by Wils, Pauline, Seksik, Philippe, Stefanescu, Carmen, Nancey, Stephane, Allez, Matthieu, Pineton de Chambrun, Guillaume, Altwegg, Romain, Gilletta, Cyrielle, Vuitton, Lucine, Viennot, Stéphanie, Serrero, Mélanie, Fumery, Mathurin, Savoye, Guillaume, Collins, Michael, Goutorbe, Felix, Brixi, Hedia, Bouguen, Guillaume, Tavernier, Noémie, Boualit, Medina, Amiot, Aurélien, Abitbol, Vered, Laharie, David, Pariente, Benjamin, Pariente, Benjamin, Nachury, Maria, Wils, Pauline, Desreumaux, Pierre, Branche, Julien, Gérard, Romain, Seksik, Philippe, Bourrier, Anne, Beaugerie, Laurent, Sokol, Harry, Kirchgesner, Julien, Stefanescu, Carmen, Bouhnik, Yoram, Treton, Xavier, Nancey, Stephane, Boschetti, Gilles, Flourié, Bernard, Gay, Claire, Danion, Pauline, Venturin, Chloe, Allez, Matthieu, Gornet, Jean‐Marc, Baudry, Clotilde, Pineton de Chambrun, Guillaume, Altwegg, Romain, Gilletta, Cyrielle, Vuitton, Lucine, Viennot, Stephanie, Serrero, Melanie, Grimaud, Jean Charles, Fumery, Mathurin, Brazier, Franck, Yzet, Clara, Collins, Michael, Goutorbe, Félix, Brixi, Hedia, Cadiot, Guillaume, Bouguen, Guillaume, Tavernier, Noémie, Boualit, Médina, Amiot, Aurélien, Gagnière, Charlotte, Tannoury, Jenny, Abitbol, Vered, Laharie, David, Rivière, Pauline, Poullenot, Florian

“…Summary Background The prevalence of inflammatory bowel diseases (IBD) is high in women of childbearing age. Achieving clinical remission from conception to…”
Get full text

Role of adherent and invasive Escherichia coli in Crohn's disease: lessons from the postoperative recurrence model by Buisson, Anthony, Sokol, Harry, Hammoudi, Nassim, Nancey, Stéphane, Treton, Xavier, Nachury, Maria, Fumery, Mathurin, Hébuterne, Xavier, Rodrigues, Michael, Hugot, Jean-Pierre, Boschetti, Gilles, Stefanescu, Carmen, Wils, Pauline, Seksik, Philippe, Le Bourhis, Lionel, Bezault, Madeleine, Sauvanet, Pierre, Pereira, Bruno, Allez, Matthieu, Barnich, Nicolas

“…We used the postoperative recurrence model to better understand the role of adherent and invasive (AIEC) bacteria in Crohn's disease (CD), taking advantage of…”
Get more information

Male gender, active smoking and previous intestinal resection are risk factors for post‐operative endoscopic recurrence in Crohn's disease: results from a prospective cohort study by Auzolle, Claire, Nancey, Stephane, Tran‐Minh, My‐Linh, Buisson, Anthony, Pariente, Benjamin, Stefanescu, Carmen, Fumery, Mathurin, Marteau, Philippe, Treton, Xavier, Hammoudi, Nassim, Jouven, Xavier, Seksik, Philippe, Allez, Matthieu, Cattan, Pierre, Chirica, Mirea, Munoz‐Bongrand, Nicolas, Corte, Hélène, Gornet, Jean‐Marc, Baudry, Clotilde, Lourenco, Nelson, Maillet, Mariane, Le Bourhis, Lionel, Chardiny, Victor, Grand, Céline, Djenidi, Faycal, Nisard, Andrée, Beaugerie, Laurent, Sokol, Harry, Bourrier, Anne, Nion‐Larmurier, Isabelle, Landman, Cecilia, Rajca, Sylvie, Quevrain, Elodie, Brot, Loic, Chafai, Najim, Lefevre, Jeremie, Tiret, Emmanuel, Svreck, Magali, Hoyau‐Idrissi, Nadia, François Flejou, Jean, Guedj, Nathalie, Panis, Yves, Magiorri, Leon, Feron, Mariane, Bouhnik, Yoram, Corcos, Olivier, Dray, Xavier, Chaput, Ulrika, Bommelaer, Gilles, Goutte, Marion, Barnich, Nicolas, Desreumaux, Pierre, Nachury, Maria, Sommeville, Coralie, Dupas, Jean‐Louis, Brazier, Franck, Chatelain, Denis, Attencourt, Christophe, Sabbagh, Charles, Leconte, Martine, Boschetti, Gilles, Flourié, Bernard, François, Yves, Cotte, Eddy, Charlois, Anne‐Laure, Falgon, Peggy, Moussata, Driffa, Chauvenet, Marion, Boyer, Sarah, Hebuterne, Xavier, Filippi, Jérome, Hofmann, Paul, Margalef, Carole, Detre, Patricia, Empana, Jean‐Philippe, Perier, Marie‐Cécile

“…Summary Background After ileocaecal resection for Crohn's disease (CD), inflammatory lesions frequently recur on the anastomosis and/or on the neo‐terminal…”
Get full text

The risk of COVID-19 in IBD patients is increased by urban living and is not influenced by disease activity or intravenous biologics by Lelong, Margaux, Josien, Régis, Coste-Burel, Marianne, Rimbert, Marie, Bressollette-Bodin, Céline, Nancey, Stéphane, Bouguen, Guillaume, Allez, Matthieu, Serrero, Mélanie, Caillo, Ludovic, Rouillon, Cléa, Blanc, Pierre, Laharie, David, Olivier, Raphaël, Peyrin-Biroulet, Laurent, Dib, Nina, De Maissin, Astrid, Montuclard, Céline, Trang-Poisson, Caroline, Vavasseur, Fabienne, Gallot, Géraldine, Berthome, Mathilde, Braudeau, Cécile, Chevreuil, Justine, Bourreille, Arnaud, Le Berre, Catherine

“…Background Patients with inflammatory bowel disease (IBD) may have a modified immune response to SARS-CoV-2. The objectives were to evaluate the prevalence of…”
Get full text

Risk of Incident Cancer in Inflammatory Bowel Disease Patients Starting Anti-TNF Therapy While Having Recent Malignancy by Poullenot, Florian, Seksik, Philippe, Beaugerie, Laurent, Amiot, Aurélien, Nachury, Maria, Abitbol, Vered, Stefanescu, Carmen, Reenaers, Catherine, Fumery, Mathurin, Pelletier, Anne-Laure, Nancey, Stephane, Peyrin-Biroulet, Laurent, Bourreille, Arnaud, Hébuterne, Xavier, Brixi, Hedia, Savoye, Guillaume, Lourenço, Nelson, Altwegg, Romain, Buisson, Anthony, Cazelles-Boudier, Christine, Racine, Antoine, Vergniol, Julien, Laharie, David

“…Patients with inflammatory bowel disease (IBD) and history of malignancy within the last 5 years are usually contraindicated for receiving anti-tumor necrosis…”
Get full text

Prevalence of Self-Reported Venous Thromboembolism and Cardiovascular Risk Factors in Patients with Ulcerative Colitis: The GETAID FOCUS Study by Guillo, Lucas, Amiot, Aurélien, Serrero, Mélanie, Altwegg, Romain, Roblin, Xavier, Atanasiu, Calina, Buisson, Anthony, Le Berre, Catherine, Reenaers, Catherine, Gornet, Jean-Marc, Laharie, David, Abitbol, Vered, Biron, Amélie, Caron, Bénédicte, Nancey, Stéphane, Chupin, Antoine, Blain, Antoine, Vuitton, Lucine, Caillo, Ludovic, Kirchgesner, Julien, Nachury, Maria, Peyrin-Biroulet, Laurent

“…Background and Aims Patients with inflammatory bowel disease have an increased risk of venous thromboembolism (VTE) and cardiovascular disease (CVD). The study…”
Get full text

Effect of COVID-19 pandemic on the workflow of endoscopy units: an international survey by Resál, Tamás, Bor, Renáta, Szántó, Kata, Fábián, Anna, Rutka, Mariann, Sacco, Marco, Ribaldone, Davide Guiseppe, Molander, Pauliina, Nancey, Stephane, Kopylov, Uri, Vavricka, Stephan, Drobne, David, Lukas, Milan, Farkas, Klaudia, Szepes, Zoltán, Molnár, Tamás

“…Introduction: The coronavirus disease 2019 (COVID-19) pandemic poses a challenge to healthcare. Staff and patients are at increased risk during an examination…”
Get full text

Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control study by Amiot, Aurelien, Bourrier, Anne, Gornet, Jean-Marc, Dewit, Olivier, Nancey, Stephane, Altwegg, Romain, Abitbol, Vered, Laharie, David, Reenaers, Catherine, Gagnière, Charlotte, Buisson, Anthony, Nachury, Maria, Viennot, Stephanie, Vuitton, Lucine, Stefanescu, Carmen, Marteau, Philippe, Bouguen, Guillaume, Seksik, Philippe

“…Whether healthcare workers with inflammatory bowel disease (IBD) are at increased risk of Novel coronavirus disease (COVID-19) due to occupational exposure is…”
Get full text

Patient preferences for adalimumab in inflammatory bowel disease: a nationwide study from the GETAID by Caron, Bénédicte, Seksik, Philippe, Buisson, Anthony, Wils, Pauline, Savoye, Guillaume, Stefanescu, Carmen, Laharie, David, Guillo, Lucas, Abitbol, Vered, Bonnet, Joelle, Altwegg, Romain, Vuitton, Lucine, Moussata, Driffa, Bourreille, Arnaud, Biron, Amélie, Gilletta, Cyrielle, Fumery, Mathurin, Nahon, Stephane, Nancey, Stephane, Camara, Houda, Peyrin-Biroulet, Laurent

“…Several adalimumab preparations are now available for patients with inflammatory bowel disease (IBD). Comparative satisfaction and tolerability are unknown…”
Get full text

Editorial: 5‐ASA in IBD patients on biologics—‘stop or continue’? by Veyrard, Pauline, Nancey, Stéphane, Roblin, Xavier

“…LINKED CONTENT This article is linked to Bernstein et al papers. To view these articles, visit https://doi.org/10.1111/apt.16518 and…”
Get full text

Editorial: proactive anti‐TNF drug monitoring in IBD—Ready for prime time? by Roblin, Xavier, Nancey, Stephane

“…LINKED CONTENT This article is linked to Sethi et al papers. To view these articles, visit https://doi.org/10.1111/apt.17313 and…”
Get full text

Abdominal necrotic abscess from colonic fistula treated endoscopically by Petit, Berenice, MD, Boschetti, Gilles, MD, Passot, Guillaume, MD, Chauvenet, Marion, MD, PhD, Cotte, Eddy, MD, PhD, Stroeymeyt, Karine, MD, Nancey, Stephane, MD, PhD, Vaudoyer, Delphine, MD, François, Yves, MD, Cabelguenne, Delphine, MD, PhD, Glehen, Olivier, MD, PhD, Flourié, Bernard, MD, PhD, Moussata, Driffa, MD, PhD

Get full text

Editorial: anti‐TNF agents against vedolizumab as a second‐line treatment? Not surprising tie game by Roblin, Xavier, Paul, Stéphane, Nancey, Stéphane

“…LINKED CONTENT This article is linked to Rundquist et al papers. To view these articles, visit https://doi.org/10.1111/apt.16193 and…”
Get full text

Comparison of short‐ and long‐term effectiveness between ustekinumab and vedolizumab in patients with Crohn's disease refractory to anti‐tumour necrosis factor therapy by Manlay, Luc, Boschetti, Gilles, Pereira, Bruno, Flourié, Bernard, Dapoigny, Michel, Reymond, Maud, Sollelis, Elisa, Gay, Claire, Boube, Mathilde, Buisson, Anthony, Nancey, Stéphane

“…Summary Background The best option between vedolizumab and ustekinumab after anti‐tumour necrosis factor (TNF) failure remains unclear in Crohn's disease. Aims…”
Get full text

Selective Autophagy Receptors in Antiviral Defense by Viret, Christophe, Duclaux-Loras, Rémi, Nancey, Stéphane, Rozières, Aurore, Faure, Mathias

“…Autophagy ensures the degradation of cytosolic substrates by the lysosomal pathway. Cargoes destined to be eliminated are confined within double-membrane…”
Get full text

A Practical Guide for Faecal Calprotectin Measurement: Myths and Realities by D’Amico, Ferdinando, Nancey, Stéphane, Danese, Silvio, Peyrin-Biroulet, Laurent

“…Abstract Background and Aims Faecal calprotectin [FC] is a valid and non-invasive marker of mucosal inflammation. It is widely used both in clinical trials and…”
Get full text

Addition of azathioprine to the switch of anti-TNF in patients with IBD in clinical relapse with undetectable anti-TNF trough levels and antidrug antibodies: a prospective randomised trial by Roblin, Xavier, Williet, Nicolas, Boschetti, Gilles, Phelip, Jean-Marc, Del Tedesco, Emilie, Berger, Anne-Emmanuelle, Vedrines, Philippe, Duru, Gerard, Peyrin-Biroulet, Laurent, Nancey, Stéphane, Flourie, Bernard, Paul, Stephane

“…In patients with IBD experiencing an immune-mediated loss of response (LOR) to antitumour necrosis factor (anti-TNF), algorithms recommend a switch of anti-TNF…”
Get more information